Novel protocol significantly improves outcomes in locally advanced pancreatic cancer

(Massachusetts General Hospital) A Massachusetts General Hospital Cancer Center clinical trial of a protocol combining intensive chemotherapy and radiation therapy with the blood pressure drug losartan has produced unprecedented results in patients with locally advanced pancreatic cancer, allowing complete removal of the tumor in 61% of participants and significantly improving survival rates.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news